{"title":"弥漫性大b细胞淋巴瘤老年营养风险指数与预后之间的年龄相互作用。","authors":"Kei Fujita, Hikaru Tsukasaki, Shin Lee, Tetsuji Morishita, Eiju Negoro, Kana Oiwa, Takeshi Hara, Hisashi Tsurumi, Takanori Ueda, Takahiro Yamauchi","doi":"10.1007/s00277-025-06477-w","DOIUrl":null,"url":null,"abstract":"<p><p>To evaluate whether age modifies the association between the geriatric nutritional risk index (GNRI) and overall survival (OS) in patients aged ≥ 18 years with newly diagnosed diffuse large B-cell lymphoma (DLBCL), we conducted a multi-centre retrospective study of 552 patients. Multivariable Cox regression with restricted cubic spline (RCS) modelling showed that GNRI was significantly associated with OS, but the relationship was non-linear (P for non-linearity = 0.0158). A three-dimensional Cox-RCS model revealed that older age was associated with a higher mortality risk. The association between lower GNRI and worse OS was consistent across all age groups, including younger patients. Among patients with low GNRI (< 92), the most common pattern of malnutrition involved normal albumin (Alb) and body mass index (BMI). This pattern accounted for approximately 40% of low-GNRI patients, regardless of age group (based on thresholds of 65, 70, or 75 years). Survival curves demonstrated that a low GNRI (< 92) predicted poor prognosis, regardless of whether Alb or BMI was the main contributing factor. There was no evidence of interaction between age and GNRI on prognosis. Malnutrition, as measured by GNRI, adversely affects survival in both younger and older DLBCL patients.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Age interaction in associations between geriatric nutritional risk index and prognosis in diffuse large B-cell lymphoma.\",\"authors\":\"Kei Fujita, Hikaru Tsukasaki, Shin Lee, Tetsuji Morishita, Eiju Negoro, Kana Oiwa, Takeshi Hara, Hisashi Tsurumi, Takanori Ueda, Takahiro Yamauchi\",\"doi\":\"10.1007/s00277-025-06477-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>To evaluate whether age modifies the association between the geriatric nutritional risk index (GNRI) and overall survival (OS) in patients aged ≥ 18 years with newly diagnosed diffuse large B-cell lymphoma (DLBCL), we conducted a multi-centre retrospective study of 552 patients. Multivariable Cox regression with restricted cubic spline (RCS) modelling showed that GNRI was significantly associated with OS, but the relationship was non-linear (P for non-linearity = 0.0158). A three-dimensional Cox-RCS model revealed that older age was associated with a higher mortality risk. The association between lower GNRI and worse OS was consistent across all age groups, including younger patients. Among patients with low GNRI (< 92), the most common pattern of malnutrition involved normal albumin (Alb) and body mass index (BMI). This pattern accounted for approximately 40% of low-GNRI patients, regardless of age group (based on thresholds of 65, 70, or 75 years). Survival curves demonstrated that a low GNRI (< 92) predicted poor prognosis, regardless of whether Alb or BMI was the main contributing factor. There was no evidence of interaction between age and GNRI on prognosis. Malnutrition, as measured by GNRI, adversely affects survival in both younger and older DLBCL patients.</p>\",\"PeriodicalId\":8068,\"journal\":{\"name\":\"Annals of Hematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00277-025-06477-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-025-06477-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Age interaction in associations between geriatric nutritional risk index and prognosis in diffuse large B-cell lymphoma.
To evaluate whether age modifies the association between the geriatric nutritional risk index (GNRI) and overall survival (OS) in patients aged ≥ 18 years with newly diagnosed diffuse large B-cell lymphoma (DLBCL), we conducted a multi-centre retrospective study of 552 patients. Multivariable Cox regression with restricted cubic spline (RCS) modelling showed that GNRI was significantly associated with OS, but the relationship was non-linear (P for non-linearity = 0.0158). A three-dimensional Cox-RCS model revealed that older age was associated with a higher mortality risk. The association between lower GNRI and worse OS was consistent across all age groups, including younger patients. Among patients with low GNRI (< 92), the most common pattern of malnutrition involved normal albumin (Alb) and body mass index (BMI). This pattern accounted for approximately 40% of low-GNRI patients, regardless of age group (based on thresholds of 65, 70, or 75 years). Survival curves demonstrated that a low GNRI (< 92) predicted poor prognosis, regardless of whether Alb or BMI was the main contributing factor. There was no evidence of interaction between age and GNRI on prognosis. Malnutrition, as measured by GNRI, adversely affects survival in both younger and older DLBCL patients.
期刊介绍:
Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.